Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

THERAPY

Metformin in pregnancy – safe or sorry?

Nature Reviews Endocrinology volume 14, pages 570–572 (2018)Cite this article

Subjects

Given the increasing incidence of overweight and obesity among young women and the subsequent high prevalence of type 2 diabetes mellitus and gestational diabetes mellitus, metformin treatment during pregnancy is increasing worldwide. A new study reports that metformin exposure in the first trimester of pregnancy does not increase the risk of congenital anomalies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Given, J. E. et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ 361, k2477 (2018).

    Article  Google Scholar 

  2. Valdes, E. et al. Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: a randomized study. J. Obstet. Gynaecol. Res. 44, 81–86 (2018).

    Article  CAS  Google Scholar 

  3. Syngelaki, A. et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434–443 (2016).

    Article  CAS  Google Scholar 

  4. Chiswick, C. et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 3, 778–786 (2015).

    Article  CAS  Google Scholar 

  5. Vanky, E., de Zegher, F., Diaz, M., Ibanez, L. & Carlsen, S. M. On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis. Acta Obstet. Gynecol. Scand. 91, 1460–1464 (2012).

    Article  Google Scholar 

  6. Ijas, H. et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118, 880–885 (2011).

    Article  CAS  Google Scholar 

  7. Rowan, J. A. et al. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358, 2003–2015 (2008).

    Article  CAS  Google Scholar 

  8. Ijas, H., Vaarasmaki, M., Saarela, T., Keravuo, R. & Raudaskoski, T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG 122, 994–1000 (2015).

    Article  CAS  Google Scholar 

  9. Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res. Care 6, e000456 (2018).

    Article  Google Scholar 

  10. Hanem, L. G. E. et al. Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs. J. Clin. Endocrinol. Metab. 103, 1612–1621 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

    Eszter Vanky & Rønnaug Ødegård

  2. Departement of Obstetrics and Gynecology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

    Eszter Vanky

  3. Centre of Obesity Research and Innovation, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

    Rønnaug Ødegård

Authors
  1. Eszter Vanky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rønnaug Ødegård
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eszter Vanky.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vanky, E., Ødegård, R. Metformin in pregnancy – safe or sorry?. Nat Rev Endocrinol 14, 570–572 (2018). https://doi.org/10.1038/s41574-018-0081-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-018-0081-6

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing